已收盘 02-06 16:00:00 美东时间
+0.370
+1.23%
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
Wells Fargo analyst Stephen Baxter maintains Pennant Gr (NASDAQ:PNTG) with a Overweight and raises the price target from $31 to $38.
01-08 05:04
William Blair analyst Jared Haase initiates coverage on Pennant Gr (NASDAQ:PNTG) with a Outperform rating.
2025-12-08 22:31
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Truist Securities analyst David Macdonald upgrades Pennant Gr (NASDAQ:PNTG) from Hold to Buy and raises the price target from $28 to $34.
2025-12-03 00:08
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
RBC Capital analyst Ben Hendrix maintains Pennant Gr (NASDAQ:PNTG) with a Outperform and raises the price target from $34 to $39.
2025-11-17 21:10
今日重点评级关注:HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从10美元升至50美元;RBC Capital:维持Precision Drilling"跑赢大市"评级,目标价从110美元升至117美元
2025-10-27 09:45
The Pennant Group, Inc. (NASDAQ: PNTG) expects to release its third quarter 2025 financial results on November 5, 2025. The company invites investors to a live webcast on November 6, 2025, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time) to discuss the results. The webcast can be accessed via the Investor Relations section of their website, along with any required SEC Regulation G information. A recording will be available until November 6, ...
2025-10-24 21:55